# DDG 2026

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/ddg-2026
Canonical HTML page: https://getbiobrief.com/entity/ddg-2026

## Recent coverage (1 stories)

### Medtrum's 300U Patch Pump with APGO Algorithm Eyes European Expansion
2026-07-27 11:03:19 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

Medtrum is advancing its 300U tubeless insulin pump toward the German market, leveraging its in-house APGO automated insulin delivery algorithm. The device’s reimbursement listing in Germany could pressure competitors like Insulet and Medtronic in the automated diabetes management space. Biopharma investors should watch for clinical evidence and partnership developments.
Full story: https://getbiobrief.com/story/medtrum-300u-patch-pump-apgo-algorithm-europe

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.